Investing Profile

Jernej Godec

InvestorVC
Principal at Atlas Venture
en.wikipedia.org/wiki/Jernej_...Cambridge, Massachusetts
Photo of Jernej Godec, Principal at Atlas Venture

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
Harvard University Network
598 CONNECTIONS
University of California, Berkeley Network
501 CONNECTIONS
Harvard University Network
87 CONNECTIONS
University of California, Berkeley Network
58 CONNECTIONS
University of California, Berkeley Network
58 CONNECTIONS
cb
Atlas Venture Principal
$10.0M - $50.0M
$25.0M
4
CompanyStageDateRound SizeTotal Raised
Diagonal Therapeutics
Series BJan 2026$130M
Series AApr 2024$130M
$250M
Co-investors: Paulina Hill (Polaris Partners), Michael Gladstone (Atlas Venture), James N. Topper (Xelas Consulting LLC)
Ethyreal Bio
Series BJan 2026$60M
Series AJun 2024$41M
$100M
Co-investors: Michael Gladstone (Atlas Venture), Mark Chin (Jmi Equity)
Tutor/Study Group Facilitator University of California, BerkeleyPresent
Research Assistant - Intern Dynavax TechnologiesPresent
Staff Research Associate University of California, BerkeleyPresent
Graduate Researcher and Postdoctoral Fellow Harvard UniversityPresent
VentureLabs Fellow and Consultant Flagship PioneeringPresent
Associate ATP (Apple Tree Partners)Present
Director, Business Development and Corporate Strategy Marengo TherapeuticsPresent
Board Observer Marengo TherapeuticsPresent
Senior Associate ATP (Apple Tree Partners)Present
Associate Atlas VenturePresent
Senior Associate Atlas VenturePresent
Principal Atlas VenturePresent
Co-Founder, Head of R&D MIFCOR, Inc.Present
University of California, Berkeley B.A. with Honors in Molecular and Cell Biology
Harvard University Ph.D. Immunology